Visteon CEO trades shares after option exercise

Visteon Corporation CEO and President Sachin Lawande reported multiple share transactions on March 4, 2026.

Rhea-AI Filing Summary

Visteon Corporation CEO and President Sachin Lawande reported multiple share transactions on March 4, 2026. He exercised 49,453 employee stock options at an exercise price of $0.00 per share, converting them into an equal number of Visteon common shares.

On the same date, he sold three blocks of common stock in open-market transactions: 25,299 shares at a weighted average price of $92.90, 17,911 shares at $93.76, and 6,243 shares at $94.69. These sales were made under a Rule 10b5-1 trading plan adopted on July 31, 2025. After these transactions, he directly held 175,527 shares, and an additional 146,229 shares were held indirectly "by SLAT" as of the latest reported line.

Insider Trade Summary

Exercise and Sale: 49,453 shares ($617K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Lawande Sachin

Role CEO and President

Sold 49,453 shs ($4.62M)

Approx. gross sale proceeds $4.62M

Approx. exercise cost $4.00M

Approx. pre-tax spread $617K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	49,453	$0.00	$0.00
Exercise	Common Stock	49,453	$80.97	$4.00M
Sale	Common Stock	25,299	$92.90	$2.35M
Sale	Common Stock	17,911	$93.76	$1.68M
Sale	Common Stock	6,243	$94.69	$591K
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 175,527 shares (Direct); Common Stock — 146,229 shares (Indirect, By SLAT)

Footnotes (6)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025.
2. F2. The options will expire if not exercised prior to March 6, 2026.
3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.37 - $93.36, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.37 - $94.36, inclusive.
5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 - $95.13, inclusive.
6. F6. The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did VISTEON CORP (VC) report for Sachin Lawande?

Sachin Lawande reported exercising 49,453 employee stock options and converting them into common stock, then selling 49,453 Visteon shares in three open-market transactions on March 4, 2026. The activity was executed under a pre-established Rule 10b5-1 trading plan.

How many VISTEON CORP (VC) shares did the CEO sell and at what prices?

On March 4, 2026, the CEO sold 25,299 shares at a weighted average price of $92.90, 17,911 shares at $93.76, and 6,243 shares at $94.69. Each group was sold in multiple trades within indicated price ranges.

Did VISTEON CORP (VC) CEO’s trades occur under a Rule 10b5-1 plan?

Yes. The filing states that all reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025. Such plans pre-schedule trades, separating them from day-to-day market decisions.

What VISTEON CORP (VC) shareholdings did Sachin Lawande report after these trades?

Following the March 4, 2026 transactions, the CEO reported direct ownership of 175,527 Visteon common shares. A separate line shows indirect ownership of 146,229 shares described as held "By SLAT," indicating an additional, indirect beneficial ownership position.

What options did the VISTEON CORP (VC) CEO exercise in this Form 4?

He exercised 49,453 employee stock options, each with a $0.00 exercise price, converting them into the same number of Visteon common shares. A footnote explains the option vested in thirds over three years and will expire if not exercised before March 6, 2026.

How were the VISTEON CORP (VC) CEO’s sale prices calculated in the Form 4?

For each sale block, the Form 4 reports a weighted average price. Footnotes state the shares were sold in multiple trades within ranges such as $92.37–$93.36, $93.37–$94.36, and $94.38–$95.13, with detailed breakdowns available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lawande Sachin

(Last) (First) (Middle)

VISTEON CORPORATION

ONE VILLAGE CENTER DRIVE

(Street)

VAN BUREN TOWNSHIP MI 48167

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VISTEON CORP [ VC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		M(1)(2)		49,453	A	$80.97	224,980	D
Common Stock	03/04/2026		S		25,299	D	$92.9(3)	199,681	D
Common Stock	03/04/2026		S		17,911	D	$93.76(4)	181,770	D
Common Stock	03/04/2026		S		6,243	D	$94.69(5)	175,527	D
Common Stock								146,229	I	By SLAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.97	03/04/2026		M(1)			49,453	(6)	03/06/2026	Common Stock	49,453	$0	0	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025.

2. The options will expire if not exercised prior to March 6, 2026.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.37 - $93.36, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.37 - $94.36, inclusive.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 - $95.13, inclusive.

6. The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.

Remarks:

	Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Sachin S. Lawande	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.